The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function.

UNLABELLED We assessed the effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic functions by comparing high-flow sevoflurane with low-flow isoflurane anesthesia. Thirty patients scheduled for surgery of > or =10 h in duration randomly received either low-flow (1 L/min) sevoflurane anesthesia (n = 10), high-flow (6-10 L/min) sevoflurane anesthesia (n = 10), or low-flow (1 L/min) isoflurane anesthesia (n = 10). We measured the circuit concentrations of Compound A and serum fluoride. Renal function was assessed by blood urea nitrogen, serum creatinine, creatinine clearance, and urinary excretion of glucose, albumin, protein, and N:-acetyl-beta-D-glucosaminidase. The hepatic function was assessed by serum aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, alkaline phosphatase, and total bilirubin. Compound A exposure was 277 +/- 120 (135-478) ppm-h (mean +/- SD [range]) in the low-flow sevoflurane anesthesia. The maximum concentration of serum fluoride was 53.6 +/- 5.3 (43.4-59.3) micromol/L for the low-flow sevoflurane anesthesia, 47.1 +/- 21.2 (21.4-82.3) micromol/L for the high-flow sevoflurane anesthesia, and 7.4 +/- 3.2 (3.2-14.0) micromol/L for the low-flow isoflurane anesthesia. Blood urea nitrogen and serum creatinine were within the normal range, and creatinine clearance did not decrease throughout the study period in any group. Urinary excretion of glucose, albumin, protein, and N:-acetyl-beta-D-glucosaminidase increased after anesthesia in all groups, but no significant differences were seen among the three groups at any time point after anesthesia. Lactate dehydrogenase and alkaline phosphatase on postanesthesia Day 1 were higher in the high-flow sevoflurane group than in the low-flow sevoflurane group. However, there were no significant differences in any other hepatic function tests among the groups. We conclude that prolonged low-flow sevoflurane anesthesia has the same effect on renal and hepatic functions as high-flow sevoflurane and low-flow isoflurane anesthesia. IMPLICATIONS During low-flow sevoflurane anesthesia, intake of Compound A reached 277 +/- 120 ppm-h, but the effect on the kidney and the liver was the same in high-flow sevoflurane and low-flow isoflurane anesthesia.

[1]  H. Higuchi,et al.  Effects of Sevoflurane and Isoflurane on Renal Function and on Possible Markers of Nephrotoxicity , 1998, Anesthesiology.

[2]  E. Kharasch,et al.  Role of the renal cysteine conjugate beta-lyase pathway in inhaled compound A nephrotoxicity in rats. , 1998, Anesthesiology.

[3]  T. Ebert,et al.  Absence of Renal and Hepatic Toxicity After Four Hours of 1.25 Minimum Alveolar Anesthetic Concentration Sevoflurane Anesthesia in Volunteers , 1998, Anesthesia and analgesia.

[4]  E. Kharasch,et al.  Absence of Biochemical Evidence for Renal and Hepatic Dysfunction after 8 Hours of 1.25 Minimum Alveolar Concentration Sevoflurane Anesthesia in Volunteers , 1998, Anesthesiology.

[5]  R. Weiskopf,et al.  Dose-Related Biochemical Markers of Renal Injury After Sevoflurane Versus Desflurane Anesthesia in Volunteers , 1997, Anesthesia and analgesia.

[6]  A. Artru,et al.  Assessment of Low‐flow Sevoflurane and Isoflurane Effects on Renal Function Using Sensitive Markers of Tubular Toxicity , 1997, Anesthesiology.

[7]  K. Ikeda,et al.  Effects of Low‐flow Sevoflurane Anesthesia on Renal Function: Comparison with High‐flow Sevoflurane Anesthesia and Low‐flow Isoflurane Anesthesia , 1997, Anesthesiology.

[8]  E. Kharasch,et al.  Role of Renal Cysteine Conjugate beta‐Lyase in the Mechanism of Compound A Nephrotoxicity in Rats , 1997, Anesthesiology.

[9]  R. Weiskopf,et al.  Nephrotoxicity of Sevoflurane Versus Desflurane Anesthesia in Volunteers , 1997, Anesthesia and analgesia.

[10]  J. G. Kenna,et al.  Sevoflurane degradation by soda lime in a circle breathing system , 1996, Anaesthesia.

[11]  K. Ikeda,et al.  Renal and Hepatic Function in Surgical Patients After Low-Flow Sevoflurane or Isoflurane Anesthesia , 1996, Anesthesia and analgesia.

[12]  P. Prokocimer,et al.  Inhalation Toxicity Study of a Haloalkene Degradant of Sevoflurane, Compound A (PIFE), in Sprague‐Dawley Rats , 1995, Anesthesiology.

[13]  E. Eger,et al.  Factors affecting the concentration of compound A resulting from the degradation of sevoflurane by soda lime and Baralyme in a standard anesthetic circuit. , 1995 .

[14]  M. Laster,et al.  Nephrotoxicity in Rats Undergoing a One-Hour Exposure to Compound A , 1995, Anesthesia and analgesia.

[15]  Ronald M. Jones,et al.  Serum Fluoride Concentration and Urine Osmolality After Enflurane and Sevoflurane Anesthesia in Male Volunteers , 1995, Anesthesia and analgesia.

[16]  K. Ikeda,et al.  Effect of total flow rate on the concentration of degradation products generated by reaction between sevoflurane and soda lime. , 1995, British Journal of Anaesthesia.

[17]  B. Brown.  Shibboleths and jigsaw puzzles. The fluoride nephrotoxicity enigma. , 1995, Anesthesiology.

[18]  E. Kharasch,et al.  Human Kidney Methoxyflurane and Sevoflurane Metabolism: Intrarenal Fluoride Production as a Possible Mechanism of Methoxyflurane Nephrotoxicity , 1994, Anesthesiology.

[19]  K. Ikeda,et al.  Plasma Inorganic Fluoride and Intracircuit Degradation Product Concentrations in Long‐Duration, Low‐Flow Sevoflurane Anesthesia , 1994, Anesthesia and analgesia.

[20]  K. Ikeda,et al.  Long‐duration, Low‐flow Sevoflurane Anesthesia Using Two Carbon Dioxide Absorbents: Quantification of Degradation Products in the Circuit , 1994, Anesthesiology.

[21]  S. Morgan,et al.  Renal Concentrating Function with Prolonged Sevoflurane or Enflurane Anesthesia in Volunteers , 1994, Anesthesiology.

[22]  E. Eger,et al.  Toxicity of Compound A in Rats: Effect of a 3‐Hour Administration , 1994, Anesthesiology.

[23]  E. Eger,et al.  Toxicity of Compound A in Rats: Effect of Increasing Duration of Administration , 1994, Anesthesiology.

[24]  Y. Ogasawara,et al.  Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. , 1992, Anesthesiology.

[25]  J. Takeda,et al.  Serum and Urinary Inorganic Fluoride Concentrations After Prolonged Inhalation of Sevoflurane in Humans , 1992, Anesthesia and analgesia.

[26]  A. J. Gandolfi,et al.  Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function. , 1992 .

[27]  S. Morgan,et al.  Plasma Inorganic Fluoride With Sevoflurane Anesthesia: Correlation With Indices of Hepatic and Renal Function , 1992, Anesthesia and analgesia.

[28]  I. Stern,et al.  Sevoflurane: A New Inhalational Anesthetic Agent , 1975, Anesthesia and analgesia.

[29]  M. Cousins,et al.  Methoxyflurane nephrotoxicity. A study of dose response in man. , 1973, JAMA.